Industrial refrigeration is key to the healthcare industry, but it contributes massively to its emissions. Several companies are starting to implement strategies to reduce these emissions, from energy ...

Abera and Orexo have entered a partnership to develop and test the powder formulations of the former’s vaccine candidates.

New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.

Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection.

Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.

Picking the right clinical partners will be critical for oncology innovators hoping to stay up to speed in a rapidly changing industry.

GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.

Manufacturing practices are evolving to advance antibody drug conjugates (ADCs) for cancer treatment through a targeted approach.

China National Medical Products Administration (NMPA) has approved MSD’s KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).

Construction has already begun on the Ozempic-producer’s new Denmark production facility and 40,000m2 warehouse.

However, caution persists:166 of 785 US venture-backed companies with an innovator drug in development have not raised capital since 2021.

Bavarian Nordic has signed a licence and manufacturing agreement with the Serum Institute of India (SII) for its mpox vaccine, MVA-BN.